European Commission funds NUDZ·$0.22mLilly buys AtaiBeckley·$3.8bnOtsuka buys Transcend·$1.2bnPfizer buys Metsera·no dollar priceAbbVie buys Gilgamesh·$1.2bnatai buys Beckley Psytech·no dollar priceAbbVie takes an option on Gilgamesh·$2bnEuropean Commission funds NUDZ·$0.22mLilly buys AtaiBeckley·$3.8bnOtsuka buys Transcend·$1.2bnPfizer buys Metsera·no dollar priceAbbVie buys Gilgamesh·$1.2bnatai buys Beckley Psytech·no dollar priceAbbVie takes an option on Gilgamesh·$2bnEuropean Commission funds NUDZ·$0.22mLilly buys AtaiBeckley·$3.8bnOtsuka buys Transcend·$1.2bnPfizer buys Metsera·no dollar priceAbbVie buys Gilgamesh·$1.2bnatai buys Beckley Psytech·no dollar priceAbbVie takes an option on Gilgamesh·$2bn
Next issueIssue 23 · Tue 17 Nov 

Companies

Metsera

Metsera, Inc.

HQ
United States
Registry
SEC EDGAR · CIK 2040807
Status
acquired
Listing
Private

sec.govregistryverified 2026-11-10

Notes on the record

Not a psychedelic company. Target in D007-pfizer-metsera-2025. Added 2026-11-10 with C021-pfizer so the deal tape can print the row (see C021). Acquired by Pfizer Inc. on November 13, 2025 (Pfizer 8-K 0000078003-25-000159, Item 8.01); Form 15-12G 0001193125-25-292197 filed 2025-11-24. EDGAR submissions API read 2026-11-10: name Metsera, Inc., no ticker, state of incorporation DE.

Assets

No asset in data/assets.csv names this company as owner.

Registered trials

No row in data/trials.csv resolves to this company's assets.

Deals

In the briefing

No published issue carries the METSERA tag.